Caliway Biopharmaceuticals
TWD86.40
0
+TWD1.90+2.25% Friday 05:30
Statistics
Day High
87.2
Day Low
81.6
52W High
277
52W Low
75.1
Volume
8,662,389
Avg. Volume
8,043,611
Mkt Cap
134.54B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.36
0.08
1.52
2.96
Expected EPS
-0.248848577775
Actual EPS
N/A
Financials
-925.2%Profit Margin
Unprofitable38.04MRevenue
-351.92MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Caliway Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the development of drugs for aesthetic medicine and chronic inflammation. The company develops CBL-514, an investigational drug, which is in Phase 2 clinical trial for non-surgical fat reduction and Dercum's disease, as well as for cellulite treatment. It is also developing CBA-539, which is in preclinical stage for central obesity, hyperpigmentation, and skin aging, as well as offers dietary supplements. The company was incorporated in 2012 and is based in New Taipei City, Taiwan.
Show more...
CEO
Mr. Antony Hsu
Country
Taiwan
ISIN
TW0006919004
Listings
0 Comments
Share your thoughts
FAQ
What is Caliway Biopharmaceuticals stock price today?▼
The current price of 6919.TW is TWD86.40 TWD — it has increased by +2.25% in the past 24 hours. Watch Caliway Biopharmaceuticals stock price performance more closely on the chart.
What is Caliway Biopharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan Stock Exchange exchange Caliway Biopharmaceuticals stocks are traded under the ticker 6919.TW.
Is Caliway Biopharmaceuticals stock price growing?▼
6919.TW stock has fallen by -13.25% compared to the previous week, the month change is a -19.63% fall, over the last year Caliway Biopharmaceuticals has showed a -66.12% decrease.
What is Caliway Biopharmaceuticals market cap?▼
Today Caliway Biopharmaceuticals has the market capitalization of 134.54B
When is the next Caliway Biopharmaceuticals earnings date?▼
Caliway Biopharmaceuticals is going to release the next earnings report on November 11, 2026.
What is Caliway Biopharmaceuticals revenue for the last year?▼
Caliway Biopharmaceuticals revenue for the last year amounts to 38.04M TWD.
What is Caliway Biopharmaceuticals net income for the last year?▼
6919.TW net income for the last year is -351.92M TWD.
In which sector is Caliway Biopharmaceuticals located?▼
Caliway Biopharmaceuticals operates in the Other sector.
When did Caliway Biopharmaceuticals complete a stock split?▼
The last stock split for Caliway Biopharmaceuticals was on July 14, 2025 with a ratio of 10000:1000.
Where is Caliway Biopharmaceuticals headquartered?▼
Caliway Biopharmaceuticals is headquartered in New Taipei City, Taiwan.